Overview of Continuous Glucose Monitoring

Monthly Searches

90,500

Competition

HIGH

Interest Over Past 5 Years

647.93%

Interest Over Past 12 Months

0.00%

Monthly searches for last 5 years

Monthly searches for last 12 months

What is "Continuous Glucose Monitoring"?

Continuous Glucose Monitoring (CGM) is a device that automatically tracks blood glucose levels throughout the day and night, giving insights into where glucose levels were, where they are, and where they are headed. CGM systems use a tiny sensor inserted under the skin on the abdomen or arm that tracks glucose levels every few minutes. It is approved for use by adults and children with a prescription and is recommended for patients on intensive insulin therapy. The average starting cost for a CGM system is around $1,000, and Medicare covers it through the durable medical equipment benefit. The major limitation of CGM is the measurement of interstitial glucose levels rather than real-time blood glucose levels, which causes a delay in treatment for hyperglycemia and hypoglycemia in patients.

Category tags for Continuous Glucose Monitoring

Company Cost System Sensor Patient Computer monitor Ketogenic diet Smartwatch FreeStyle Continuous glucose monitor Blood Sugar Pump Insulin pump Continuous function Heart rate Weight loss ICD-10 Ketone Monitoring Platform Research Healthcare Endocrinology Patient care Diabetes Medical technology Health monitoring

RamenApps Analysis

Continuous Glucose Monitoring has gained a significant level of interest over time, with a current monthly search volume of 40500 and a high competition index. This indicates a growing demand for devices that can constantly monitor blood glucose levels without the need for manual testing. The associated trends and search terms also suggest increasing interest in the technology among people with diabetes and those seeking to manage their blood glucose levels for weight loss or general health purposes. However, the limitation of CGM in measuring interstitial glucose levels instead of real-time blood glucose levels could still cause a delay in treatment for hyperglycemia and hypoglycemia. The projected future of Continuous Glucose Monitoring looks promising, with improving technology and increasing adoption. With newer and more advanced CGM devices entering the market, we can expect to see an even greater demand from patients and higher sales for companies developing and distributing the technology.